Research for patient’s care
Web page financed by
PROMETEO 13/005
INDEST is part of
MyPath
https://mypath-cancercare.eu/
Horizon Europe Funded project under GA Nº101057514
INDEST is part of
MOTRICOLOR
www.motricolor.eu
H2020 Funded project under GA 635342

OBJECTIVES

One of the main objectives of our group is to help in the development of new therapies and diagnostic methods in cancer. For this, we have a large clinical and research team.

LEER MÁS

RESEARCH

The basis of our research is the study of molecular causes and genetic alternations in tumor processes, using the new techniques and technologies available in the market.

LEER MÁS

PATIENTS

Both, our clinical practice and our scientific research, is centred on improving the well-being of patients, trying to optimize treatments in a personalized way.

LEER MÁS

COMMUNICATION

It is important that not only the medical and scientific community is aware of the discoveries made by researchers in our group, but also the rest of the society.

LEER MÁS

Funding agencies

Recent publications
Predoctoral Research job offer at Dr. Cervantes group

DESCRIPTION An outstanding opportunity has arisen for a

Dr. Cervantes, new director of INCLIVA

After the abdication of the Directors of the Research

Dr. Cervantes is awarded with the Merck Research Award 2017 in Colorectal Cancer

In the 26th edition of Merck Research Grants, the Merck

Puçol supports the fight against cancer

Puçol had organized last Sunday 6th of March, within the

Gloria Ribas participates in the II Meeting of Researchers in Cancer

Last March 24th, the city of Alcoy (Alicante) promoted the

InDeST, one of the CIBER-ONC groups

The Institute of Health Carlos III (ISCIII) has increased

Bootcamp de programación y curso de analista de datos en México